Janus Henderson Group PLC decreased its stake in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN – Free Report) by 72.1% during the first quarter, Holdings Channel reports. The firm owned 13,000 shares of the company’s stock after selling 33,674 shares during the quarter. Janus Henderson Group PLC’s holdings in Guardian Pharmacy Services were worth $490,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Ameritas Investment Partners Inc. grew its position in Guardian Pharmacy Services by 26.5% in the 3rd quarter. Ameritas Investment Partners Inc. now owns 1,647 shares of the company’s stock worth $43,000 after purchasing an additional 345 shares during the period. Raymond James Financial Inc. bought a new position in shares of Guardian Pharmacy Services during the 2nd quarter valued at $43,000. Strs Ohio bought a new position in shares of Guardian Pharmacy Services during the 4th quarter valued at $75,000. Clearstead Advisors LLC boosted its stake in shares of Guardian Pharmacy Services by 196.3% in the 4th quarter. Clearstead Advisors LLC now owns 2,628 shares of the company’s stock worth $79,000 after buying an additional 1,741 shares during the last quarter. Finally, State of Wyoming purchased a new position in shares of Guardian Pharmacy Services in the 2nd quarter worth $58,000.
Analyst Upgrades and Downgrades
Several analysts recently commented on the company. Zacks Research lowered Guardian Pharmacy Services from a “strong-buy” rating to a “hold” rating in a report on Monday, May 11th. Truist Financial raised their target price on Guardian Pharmacy Services from $43.00 to $47.00 and gave the stock a “buy” rating in a research report on Wednesday, June 17th. Wall Street Zen upgraded Guardian Pharmacy Services from a “hold” rating to a “buy” rating in a research note on Sunday. Weiss Ratings upgraded Guardian Pharmacy Services from a “hold (c)” rating to a “hold (c+)” rating in a research note on Thursday. Finally, Bank of America upped their price target on shares of Guardian Pharmacy Services from $42.00 to $47.00 and gave the company a “buy” rating in a research report on Wednesday, June 17th. Seven analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $43.83.
Guardian Pharmacy Services Trading Down 6.3%
Shares of NYSE:GRDN opened at $41.06 on Tuesday. The stock has a 50 day moving average of $40.96 and a 200 day moving average of $37.25. The company has a market cap of $2.04 billion, a PE ratio of 39.86, a price-to-earnings-growth ratio of 2.87 and a beta of 0.11. Guardian Pharmacy Services, Inc. has a 12-month low of $19.30 and a 12-month high of $47.02.
Guardian Pharmacy Services (NYSE:GRDN – Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The company reported $0.29 earnings per share for the quarter, beating the consensus estimate of $0.26 by $0.03. The business had revenue of $351.77 million for the quarter, compared to the consensus estimate of $340.45 million. Guardian Pharmacy Services had a net margin of 4.50% and a return on equity of 29.97%. Equities research analysts predict that Guardian Pharmacy Services, Inc. will post 1.18 earnings per share for the current fiscal year.
Guardian Pharmacy Services Profile
Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.
Featured Articles
- Five stocks we like better than Guardian Pharmacy Services
- SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat
- 3 Dividend Champion Utilities for a Market That Can’t Sit Still
- These 3 Most-Upgraded Stocks Have Almost Nothing to Do With AI
- First Solar’s Profit Engine Faces a New Policy Test in Washington
Want to see what other hedge funds are holding GRDN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Guardian Pharmacy Services, Inc. (NYSE:GRDN – Free Report).
Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.
